Aligos Therapeutics Inc. (ALGS): Price and Financial Metrics

Aligos Therapeutics Inc. (ALGS): $18.20

0.30 (-1.62%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ALGS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#203 of 332

in industry

ALGS Price/Volume Stats

Current price $18.20 52-week high $30.00
Prev. close $18.50 52-week low $6.76
Day low $17.88 Volume 496,400
Day high $19.85 Avg. volume 80,093
50-day MA $10.59 Dividend yield N/A
200-day MA $15.33 Market Cap 65.30M

ALGS Stock Price Chart Interactive Chart >


Aligos Therapeutics Inc. (ALGS) Company Bio


Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.


ALGS Latest News Stream


Event/Time News Detail
Loading, please wait...

ALGS Latest Social Stream


Loading social stream, please wait...

View Full ALGS Social Stream

ALGS Price Returns

1-mo 147.96%
3-mo 31.60%
6-mo 25.52%
1-year 7.06%
3-year -95.49%
5-year N/A
YTD 9.64%
2023 -30.32%
2022 -91.97%
2021 -57.07%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!